{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2021/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Mark T. Bilodeau", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ma_ln:bilodeau-2"}]}

Home › 2021 › Merck › Mark T. Bilodeau

Mark T. Bilodeau — 1 Patent in 2021

TTTarveda Therapeutics: 1 patents #1 of 8Top 15%

Concord, MA: #45 of 115 inventorsTop 40%

Massachusetts: #4,998 of 14,123 inventorsTop 40%

Overall (2021): #354,933 of 548,734Top 65%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11160871	SSTR-targeted conjugates and particles and formulations thereof	Richard Wooster, Kerry Whalen, Patrick Rosaire Bazinet, Sudhakar Kadiyala, Samantha Perino +2 more	2021-11-02

Mark T. Bilodeau — 1 Patent in 2021

Issued Patents 2021

Patent Widget